IRIS
VINCENZI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 21.268
NA - Nord America 8.392
EU - Europa 3.922
SA - Sud America 1.305
AF - Africa 175
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 35.123
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 14.956
US - Stati Uniti d'America 8.095
CN - Cina 2.769
HK - Hong Kong 2.098
IT - Italia 1.886
BR - Brasile 946
GB - Regno Unito 608
VN - Vietnam 561
FR - Francia 525
DE - Germania 271
IN - India 233
AR - Argentina 143
CA - Canada 137
NL - Olanda 132
MX - Messico 116
ID - Indonesia 82
ZA - Sudafrica 76
TR - Turchia 74
BD - Bangladesh 73
JP - Giappone 73
FI - Finlandia 66
UA - Ucraina 62
AU - Australia 52
PL - Polonia 52
ES - Italia 47
IQ - Iraq 45
CO - Colombia 44
SA - Arabia Saudita 44
EC - Ecuador 42
RU - Federazione Russa 37
SE - Svezia 34
CL - Cile 31
PY - Paraguay 31
PH - Filippine 30
UZ - Uzbekistan 27
PE - Perù 26
CZ - Repubblica Ceca 25
EE - Estonia 25
PK - Pakistan 23
VE - Venezuela 23
AT - Austria 20
CH - Svizzera 20
BE - Belgio 16
LT - Lituania 15
TW - Taiwan 14
KE - Kenya 13
AZ - Azerbaigian 12
EG - Egitto 12
KR - Corea 12
MY - Malesia 12
TN - Tunisia 12
BH - Bahrain 11
NP - Nepal 11
TH - Thailandia 11
UY - Uruguay 11
AE - Emirati Arabi Uniti 10
MA - Marocco 10
RO - Romania 10
IL - Israele 9
IR - Iran 9
JO - Giordania 9
PS - Palestinian Territory 9
DZ - Algeria 8
PT - Portogallo 8
SI - Slovenia 8
OM - Oman 7
RS - Serbia 7
AL - Albania 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
GT - Guatemala 6
KZ - Kazakistan 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
GR - Grecia 5
IE - Irlanda 5
JM - Giamaica 5
LB - Libano 5
SN - Senegal 5
BG - Bulgaria 4
BO - Bolivia 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
DM - Dominica 4
GH - Ghana 4
KW - Kuwait 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
BF - Burkina Faso 3
BY - Bielorussia 3
CY - Cipro 3
HN - Honduras 3
HU - Ungheria 3
LV - Lettonia 3
ML - Mali 3
SK - Slovacchia (Repubblica Slovacca) 3
TJ - Tagikistan 3
BB - Barbados 2
CG - Congo 2
Totale 35.064
Salva come PNG Salva come JPEG
Città #
San Jose 2.880
Hong Kong 2.071
Ashburn 1.997
Singapore 1.950
Rome 1.331
Hefei 1.086
Boardman 659
Beijing 585
London 508
Lauterbourg 473
Dallas 444
Shanghai 359
Ho Chi Minh City 196
Los Angeles 161
Council Bluffs 135
Hanoi 125
San Francisco 123
Munich 101
São Paulo 97
Santa Clara 93
New York 87
Amsterdam 85
Pune 79
Toronto 73
Mexico City 72
Seattle 68
Washington 54
Milan 51
Tokyo 49
Warsaw 48
Johannesburg 42
Frankfurt am Main 41
Turku 40
Chennai 37
Rio de Janeiro 35
Brooklyn 34
Chicago 29
Montreal 27
Melbourne 26
Stockholm 26
Boston 25
Da Nang 25
Helsinki 25
Orem 24
St Louis 23
Tashkent 23
Riyadh 22
Brno 20
Biên Hòa 19
Haiphong 19
Secaucus 19
Buenos Aires 18
Belo Horizonte 17
New Delhi 17
Ankara 16
Asunción 16
Curitiba 16
Manchester 16
Naples 15
Atlanta 14
Baghdad 14
Charlotte 14
Istanbul 14
Phoenix 14
Sydney 14
The Dalles 14
Denver 13
Guangzhou 13
Jeddah 13
Thái Bình 13
Canberra 12
Central 12
Hasselt 12
Nairobi 12
Palermo 12
Porto Alegre 12
Quito 12
West Jordan 12
Brasília 11
Hangzhou 11
Lima 11
Santiago 11
Turin 11
Bologna 10
Medellín 10
Ribeirão Preto 10
Salvador 10
Amman 9
Baku 9
Bogotá 9
Dhaka 9
Fortaleza 9
Hanover 9
Manaus 9
Manila 9
Modena 9
Mumbai 9
Ninh Bình 9
Nuremberg 9
Osasco 9
Totale 17.210
Salva come PNG Salva come JPEG
Nome #
Aspetti etico-clinici del percorso decisionale ed assistenziale per la sedazione palliativa 331
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 291
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: An open-label, non randomized, pilot study 268
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss 254
A novel predictive biomarker of immunotherapy response in metastatic renal cell carcinoma (mRCC): The lymphocyte microRNA expression profile. 247
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 244
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 244
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 241
Doctor-patient communication tricks. Ontological study a Campus Bio-Medico University of Rome 240
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 237
ANGIOGENESIS AND ONCOGENES IN COLON CANCER 236
Cardiotossicità da antracicline 231
COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables 231
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 231
S-Adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury 227
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 219
Cyclooxygenase-2 overexpression is associated with a poor outcome in resected ampullary cancer patients 219
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions 218
Sarcopenia Does Not Impact the Outcome of Patients with Multiple Myeloma Consolidated with Autologous Hematopoietic Stem Cell Transplantation 216
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features 216
Premetastatic niche: ready for new therapeutic interventions? 214
Prevention of radiotherapy-induced emesis 214
Bevacizumab in association with de Gramont 5-fluorouracil/folinic acid in patients with oxaliplatin-, irinotecan-, and cetuximab-refractory colorectal cancer: a single-center phase 2 trial 212
Enoxiparin effects depend on body-weight and current doses my be inadequate in obese patients 211
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma 211
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 210
Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). 209
Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients 208
Bisphosphonate effects in cancer and inflammatory diseases: in vitro and in vivo modulation of cytokine activities 206
Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients 205
Urinary complications from breast cancer metastasis: case report and review of the literature 204
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters 203
A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma 202
Bisphosphonates: new antiangiogenic molecules in cancer treatment? 201
Survey on learning needs and preferred sources of information to meet these needs in Italian oncology patients receiving chemotherapy 200
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma 198
Complications of therapy in cancer patients: Case 3. Toxic epidermal necrolysis induced by oral phenobarbital and whole-brain radiotherapy in a breast cancer patient 197
Gemcitabine-induced atrial fibrillation: A hitherto unreported manifestation of drug toxicity 196
A staphylococcus aureus coinfection on a COVID-19 pneumonia in a breast cancer patient 196
Docetaxel induced pericardial effusion 196
CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients 194
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 194
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 190
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 190
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients 176
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients 166
A giant sarcoma of the parotid gland: A case report and review of the literature 159
'Internal bracing' surgery in the management of solid tumor metastases of the thoracic and lumbar spine 153
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 152
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 146
Liver harvesting surgical technique for the treatment of retro-hepatic caval thrombosis concomitant to renal cell carcinoma: perioperative and long-term results in 15 patients without mortality 143
Bilateral irreversible hearing loss associated with the combination of carboplatin and paclitaxel chemotherapy: a unusual side effect 139
'Old' and 'new' drugs for the treatment of cancer pain 137
Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome 136
Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma 135
An international survey on the use of guidelines for palliative sedation therapy 132
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 132
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients 131
A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid 130
Circulating endothelial cell (CEC) kinetic in patients with Multiple Myeloma (MM) who receive Au-HSCT (Autologous Hematopoietic Stem Cell Transplantation) 129
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 129
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review 129
Carcinoma of the Ampulla of Vater morphological and immunophenotypical classification predicts overall survival 125
Biological effects of cabozantinib on bone microenvironment 125
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 124
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 123
An increase of CA 19.9 as the first clinical sign of ileocecal valve metastasis from breast cancer 122
Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours 121
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial 120
Italian translation of the Manchester-Oxford Foot Questionnaire (MOXFQ), with re-assessment of reliability and validity 120
Circulating VEGF reduction, response and outcome in advanced colorectal cancer patients treated with cetuximab plus irinotecan 118
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 118
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 115
Activity of sirolimus in advanced epithelioid hemangioendothelioma (EHE): A retrospective analysis within the Italian Rare Tumor Network (RTR). 115
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin 115
Continuous infusion of oxaliplatin plus chronomodulated capecitabine in 5-fluorouracil- and irinotecan-resistant advanced colorectal cancer patients 114
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 114
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 114
Cardiotoxicity of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Pathophysiology, Clinical Implications, and Echocardiographic Assessment 113
Adenogenesis Factors FGF7, FGF10, FGF23, IFN-τ and HGF in Endometriosis Tissue Respect to Eutopic Endometrium: An Immunohistochemical Study 113
A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl) 112
Azygo-tracheal fistula in a complete implantable central venous system 112
In vivo effects of zoledronic acid on peripheral gamma delta T lymphocytes in early breast cancer patients 111
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 110
Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response 110
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 110
Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated 109
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 109
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 109
Atypical chronic head and neck pain: don't forget Eagle's syndrome 109
Idiosyncratic reaction after oxaliplatin infusion 108
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients 108
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes 107
Persisting perianal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation-related complication? 104
Cox-2 Expression in Different Histotypes of Ampullary Carcinoma 104
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 101
Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6 99
Fatal thrombocytopenia and thrombocytopathia: An unusual onset of non small cell lung cancer 98
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients 97
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 96
Totale 16.508
Salva come PNG Salva come JPEG
Categoria #
all - tutte 249.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 249.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022753 0 9 12 4 49 12 10 9 24 23 26 575
2022/2023194 23 7 3 14 7 8 19 15 15 7 69 7
2023/20241.888 49 213 155 165 156 766 27 113 27 53 81 83
2024/202517.397 277 217 719 138 146 420 296 76 1.521 1.321 5.821 6.445
2025/202615.069 1.506 684 1.068 1.806 640 1.043 4.379 1.462 1.403 1.078 0 0
Totale 35.301